Press releases

10 December, 2018

Regulatory

Outcome of the Exercise of Warrants in NeuroVive

Lund, Sweden, 10 December 2018 –NeuroVive Pharmaceutical AB (publ) (“NeuroVive” or “the Company”) (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announces the outcome of the exercise of warrants of serie ...

31 October, 2018

Regulatory

NeuroVive today announces that the subscription period for warrants of series 2018:1 will begin on Thursday, November 1

Lund, Sweden October 31 2018 – NeuroVive Pharmaceutical AB (publ) (”NeuroVive” or ”the Company”) (Nasdaq Stockholm: NVP, OTCQX: NEVPF) announces today that the subscription period for the warrants of ...

26 March, 2018

Regulatory

Notice of Annual General Meeting of Shareholders in NeuroVive Pharmaceutical AB

The Board of Directors of NeuroVive Pharmaceutical AB (publ) has issued a notice to the Annual General Meeting, which is to take place on Friday, April 27, 2017, at 10 am at Medicon Village, Scheelevä ...

22 March, 2018

Regulatory

NeuroVive Pharmaceutical AB (publ): report from EGM

Today, 22 March 2018, an extraordinary general meeting was held in NeuroVive Pharmaceutical AB (publ) ("NeuroVive" or the "Company"). A summary of the resolutions follows. All resolutions were passed ...

20 February, 2018

Regulatory

NeuroVive Pharmaceutical AB Year End Report January – December 2017

Strong trend for mitochondrial disorder projects

15 February, 2018

Regulatory

Notice of Extraordinary General Meeting of NeuroVive Pharmaceutical AB (publ)

The shareholders of NeuroVive Pharmaceutical AB (publ), 556595-6538, are hereby convened to the Extraordinary General Meeting, held at 2 pm on Thursday 22 March 2018 at Medicon Village, Scheelevägen 2 ...

27 April, 2017

Regulatory

Resolutions from Annual General Meeting in NeuroVive Pharmaceutical AB (publ)

Lund, Sweden, 27 April 2017 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) ("NeuroVive") today on 27 April 2017 held its Annual General Meeting (AGM). A summary of the resolutions ...

23 March, 2017

Regulatory

Notice of Annual General Meeting of Shareholders in NeuroVive Pharmaceutical AB

The Board of Directors of NeuroVive Pharmaceutical AB (publ) has issued a notice to the Annual General Meeting, which is to take place on Thursday, April 27, 2017, at 4 pm at Medicon Village, Scheelev ...

22 November, 2016

Regulatory

NeuroVive Pharmaceutical AB Interim Report January – September 2016

New business model generates opportunities

18 March, 2015

Regulatory

NeuroVive Pharmaceutical publishes English version of annual report for 2014

NeuroVive Pharmaceutical AB (publ) today announced that the English version of the annual report for 2014 is now available on the company's website www.neurovive.com.The annual report can also be acce ...

17 April, 2014

Regulatory

NeuroVive Pharmaceutical’s 2013 Annual Report now available

Today, NeuroVive Pharmaceutical AB (publ) announced that the Annual Report for 2013 is available as PDF at www.neurovive.com, and can be read via the link below. The available report is in Swedish. An ...